Riskpilot← Back to searchSign inGet full accessFILLOX THERESESGATE AS
ASActiveOrg 926832832Dronning Margretes vei 11, 0663 OsloOther human health activities n.e.c. · NACE 8699Est. 20211 employees
Revenue 2024
NOK 3,4M
-39% vs 2023
EBITDA margin
-28.0%
-1715% vs 2023
Equity ratio
-115.6%
Financial strength
Net profit 2024
NOK -1M
-762% vs 2023
| Revenue | NOK 3,4M | -39% |
| EBITDA | NOK -945K | -1715% |
| Net profit | NOK -1M | -762% |
| Total assets | NOK 1,3M | -11% |
| Equity | NOK -1,5M | -225% |
| Employees | 1 | — |
Legal name
FILLOX THERESESGATE AS
Org number
926832832
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
22. mars 2021
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Medisinsk og estetisk behandling og andre helsetjenester.
Address
Dronning Margretes vei 11, 0663 Oslo
Phone
+4748480700
Email
kontakt@fillox.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 1 401 | 3 931 | 5 568 | 3 373 |
| Staff expenses | −326 | −587 | −947 | −1 104 |
| EBITDA | −2 008 | −541 | −52 | −945 |
| Depreciation & amort. | −41 | −66 | −65 | −60 |
| EBIT | −2 048 | −607 | −117 | −1 005 |
| Net financials | −57 | −36 | 1 | −0 |
| Profit before tax | −2 105 | −643 | −117 | −1 006 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −2 105 | −643 | −117 | −1 006 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 934 | 1 216 | 1 413 | 1 258 |
| Equity | 312 | −331 | −447 | −1 453 |
| Long-term debt | 50 | 658 | 658 | 658 |
| Short-term debt | 572 | 889 | 1 202 | 2 053 |
| Total debt | 622 | 1 546 | 1 860 | 2 711 |
EBITDA margin
-28.0%
This company
15.8%
Market median
-277% vs market
20212024
Equity ratio
-115.6%
This company
38.2%
Market median
-403% vs market
20212024
Return on equity
-100583000.0%
This company
18.4%
Market median
-546646839% vs market
20212024
Net profit margin
-29.8%
This company
8.1%
Market median
-468% vs market
20212024
Asset turnover
2.68×
This company
1.12×
Market median
+139% vs market
20212024
Debt / equity
1.87×
This company
0.62×
Market median
-202% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-27 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TH Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 65% | 65% | 2024 | |
| Company | 20% | 20% | 2024 | |
| Company | 10% | 10% | 2024 | |
| Company | 5% | 5% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Justyna Holding As
FILLOX THERESESGATE AS Board members of FILLOX THERESESGATE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Haugland | Chief Executive Officer | 0 companies |
| Justyna Rundberg | Board of Directors | 0 companies |
| Justyna Kupiec | Board of Directors | 0 companies |
| Anette Lynne | Chairman | 0 companies |